Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1157382.RA9N5HkJW4e4YyqeCY_4AiSjRTY-ztVLzhis-cxbw6kWw130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157382.RA9N5HkJW4e4YyqeCY_4AiSjRTY-ztVLzhis-cxbw6kWw130_provenance.
• NP1157389.RA34bGgD1rFw24ZkEuanDH4OBy4s3ZjmLVBD5MX_AsZWg130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157389.RA34bGgD1rFw24ZkEuanDH4OBy4s3ZjmLVBD5MX_AsZWg130_provenance.
• NP1157399.RA1x2ud0atCbIn7V3XUAWPUu50Kv73GrAzrNL0kIe8wb8130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157399.RA1x2ud0atCbIn7V3XUAWPUu50Kv73GrAzrNL0kIe8wb8130_provenance.
• NP1157390.RAbsVktSCf1WZiKsDavy_LjYPKkT0LNCNDXdygetngSUI130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157390.RAbsVktSCf1WZiKsDavy_LjYPKkT0LNCNDXdygetngSUI130_provenance.
• NP1157392.RAV4JJo05kKf7oQy8WHBkBZZGnhoaJzee0C_4ygRVPfOA130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157392.RAV4JJo05kKf7oQy8WHBkBZZGnhoaJzee0C_4ygRVPfOA130_provenance.
• NP1157396.RAQ7DWOIdEFW7DjL-FLIWCEYxaJZP8U55dLl04OG0Kx0o130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157396.RAQ7DWOIdEFW7DjL-FLIWCEYxaJZP8U55dLl04OG0Kx0o130_provenance.
• NP1157401.RAd_mEYQnitVZ6ym8s_r4CqmS3BG77yl3M3a2Mn6hywFw130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157401.RAd_mEYQnitVZ6ym8s_r4CqmS3BG77yl3M3a2Mn6hywFw130_provenance.
• NP1157403.RAb-LdZ_xYJWI1Gq0KXVSHcApEkwy5iia8vw6jU23JZeo130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157403.RAb-LdZ_xYJWI1Gq0KXVSHcApEkwy5iia8vw6jU23JZeo130_provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1157385.RANM8LofKnT1r3pRUx3suDpYJYgfI5pZNiHBXnT1ZEyeo130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157385.RANM8LofKnT1r3pRUx3suDpYJYgfI5pZNiHBXnT1ZEyeo130_provenance.
• NP1157387.RAKIVxQ6dOwzjoKRQQt-8w63fln0_K7VjBTT6GonRExiI130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157387.RAKIVxQ6dOwzjoKRQQt-8w63fln0_K7VjBTT6GonRExiI130_provenance.
• NP1157395.RAOQUOjWb8LI7DjglV6A9Ye7HuagiFGiZ2EsGngLePw3w130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157395.RAOQUOjWb8LI7DjglV6A9Ye7HuagiFGiZ2EsGngLePw3w130_provenance.
• NP1157400.RAMilkxJQrPVQNL-spyWe1alAdiz7M1CFJkaomwASTuIQ130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157400.RAMilkxJQrPVQNL-spyWe1alAdiz7M1CFJkaomwASTuIQ130_provenance.
• NP1157402.RAL3oym3QrU-08fNOmOB-15YEuQvMOMqqujOH62hPXCbY130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157402.RAL3oym3QrU-08fNOmOB-15YEuQvMOMqqujOH62hPXCbY130_provenance.
• NP1157388.RAlBb3tL8LaEsFhcdxzwz-_WFlyZiH60GVEaFui57EyXQ130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157388.RAlBb3tL8LaEsFhcdxzwz-_WFlyZiH60GVEaFui57EyXQ130_provenance.
• NP1157397.RAlhO5MNQoeD-M5rQ5eOcVtC88wQlWYZOrQDD6g4FbW6Q130_assertion description "[Alterations in the PI3K pathway are prevalent in endometrial cancer due to PIK3CA mutation and loss of PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157397.RAlhO5MNQoeD-M5rQ5eOcVtC88wQlWYZOrQDD6g4FbW6Q130_provenance.